Use of a combination of pentoxifylline with type - i - interferons for the treatment of multiple sclerosis

• 1. 应用共有干扰素治疗多发性硬化症病人的方法 [P] . 中国专利： CN1267225A . 2000-09-20
• 2. 用拉喹莫德与干扰素-β的组合治疗多发性硬化症 [P] . 中国专利： CN103781355A . 2014-05-07
• 3. Use of a combination of pentoxifylline with type - i - interferons for the treatment of multiple sclerosis [P] . NO982463D0 . 1998-05-29

  机译： 己酮可可碱与i型干扰素的联合应用治疗多发性硬化症。

• 4. USE OF A COMBINATION OF PENTOXIFYLLINE AND TYPE I INTERFERONS FOR TREATING MULTIPLE SCLEROSIS [P] . HU9903698A2 . 2000-03-28

  机译： 五线谱和I型干扰素联合治疗多发性硬化症的应用

• 5. Combination of pentoxifylline and type I interferons for treating multiple sclerosis [P] . 日本专利： JP2000501085A . 2000-02-02

  机译： 己酮可可碱和I型干扰素联合治疗多发性硬化症

• 1. Using a Combination of Artificial Neural Networks for the Diagnosis of Multiple Sclerosis [C] . Angel GUTIERREZ, Carlos FERNANDEZ GARCiA World multi-conference on systemics, cybernetics and informatics;WMSCI 2011 . 2012
• 2. Immunobiological studies of interferons in multiple sclerosis. [D] . Nguyen, Linh Thuy. 2001
• 3. The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy safety or dosing of different interferon beta formulations alone or in combination [O] . Volker Limmroth, Norman Putzki, Norman J. Kachuck 2011
• 4. The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination [O] . Limmroth, Volker, Putzki, Norman, Kachuck, Norman J. 2011

• 1. Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a [J] . Eckart Schott ,Friedemann Paul ,Jens T Wuerfel . 世界胃肠病学杂志：英文版 . 2007,第26期
• 2. Interferon-γ mRNA attenuates its own translation by activating PKR： A molecular basis for the therapeutic effect of interferon-β in multiple sclerosis [J] . Raymond Kaempfer . 细胞研究：英文版 . 2006,第2期
• 3. High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-a monotherapy [J] . Holger G. Hass ,Christian Kreysel ,Johannes Fischinger . 世界胃肠病学杂志：英文版 . 2005,第34期
• 4. Intrathecal IgG synthesis in relapsing-remitting multiple sclerosis (MS) is decreased by natural human alpha interferon [J] . William A. Sheremata ,Alan Sazant ,Vincent Riesgo . 生命科学与技术进展（英文） . 2013,第7期
• 5. Association of Human Herpesvirus 6 and 8 in Relapsing Remitting Multiple Sclerosis Type during Exacerbation [J] . Hassan Salama ,Mohamed El-Khateeb ,Rawya Bader . 神经系统科学与医药（英文） . 2010,第1期
• 6. 风湿Ⅲ号方联合小剂量糖皮质激素治疗脾肾阳虚、血瘀经脉型系统性硬化症的临床观察 [C] . 张澜 ,王吉安 ,宋欣伟 . 浙江省中医药学会2016年风湿病分会学术年会 . 2017
• 7. 应用Markov模型对干扰素β-1α与干扰素β-1b治疗复发缓解型多发性硬化进行成本效果分析 [A] . 李红艳 . 2016